Net Sales
Breakdown
Segments
Infusion Therapies & TechnologiesView metric
Advanced SurgeryView metric
Care & Connectivity SolutionsView metric
Front Line CareView metric
Injectables & AnesthesiaView metric
Drug CompoundingView metric
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Infusion Therapies & Technologies | $1.05B | $1.07B | $1.02B | $994M | $1.02B | $1.02B | $1.06B | $981M |
| Care & Connectivity Solutions | $452M | $456M | $504M | $427M | $474M | $473M | $537M | $435M |
| Drug Compounding | $261M | $267M | $260M | $246M | $280M | $299M | $316M | $320M |
| Advanced Surgery | $277M | $272M | $292M | $268M | $296M | $306M | $328M | $304M |
| Injectables & Anesthesia | $341M | $321M | $383M | $335M | $332M | $333M | $352M | $301M |
| Front Line Care | $296M | $296M | $280M | $277M | $293M | $300M | $290M | $270M |
| Total | $2.69B | $2.7B | $2.75B | $2.63B | $2.81B | $2.84B | $2.97B | $2.7B |